IJCEMR
ELISA Project—Detection, Optimizing, and Validation of Von Willebrand Factor
TOTAL VIEWS: 351
Abstract
The enzyme-linked immunosorbent assay (ELISA) is standardized and validated in order to identify and quantify levels of plasma von Willebrand factor (vWF) for a routine check-up and diagnostic method for immune-mediated TTP patients. The kind of ELISA method in this project is a sandwich ELISA in plasma vWF that binds to a primary antibody (a polyclonal rabbit anti-human vWF antibody). It is coated with primary antibody in the plate and sandwiched in between with secondary antibody bond to fluorescent marker, horseradish peroxidase (HRP). In this project, the optimal absorption is recorded by a microplate ELISA reader at 450nm. The optimal concentration of primary antibody, plasma, and secondary antibody is 1:800, 1:40, and 1:8000 respectively. The linearity of the standard curve is established with an average R2 value of 0.99. The lower limit in the experiment is 3.13%/1:1280. The quality controls, QC1 and QC2, are within the reference range. Finally, it is noted that plasma samples are measured by ELISA. Due to time limitations, intra, inter-assay and the upper limits of the range are not analyzed thoroughly.
References
[1] Sukumar S, Lämmle B, Cataland SR. Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management. J Clin Med. 2021;10(3):57.
[2] Scully M, Dutt T, Lester W, Farrington E, Lockwood S, Perry R, et al. Unmet needs in the management of immune-mediated thrombotic thrombocytopenic purpura and the potential role of caplacizumab in the UK—A modified-Delphi study. EJHaem. 2022;3(3):619-627.
[3] Cardesa-Salzmann TM, Bernhard S, Simon A, Furtwängler R, Schöndorf D, Heine S, et al. Immune-mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab. Clin Case Rep. 2022;10(5).
[4] Ulanova M, Huska B, Dubois S, McCready W. Opsonophagocytic activity against Streptococcus pneumoniae in Indigenous and non-Indigenous patients with severe chronic kidney disease immunized with 13-valent pneumococcal conjugate vaccine. Vaccine. 2022 Jul 1;40(3):4594-4602.
[5] Kankana K, Sviatlana M, Benno E, Merl-Pham Juliane, Griebler C, Elsner M. Defining lower limits of biodegradation: atrazine degradation regulated by mass transfer and maintenance demand in Arthrobacter aurescens TC1. ISME J. 2019;13(9): 2236-2251.
[6] Martins V, Wilsher N, Song L, Oganesian A. A validated liquid chromatography-tandem mass spectroscopy method for the quantification of tolinapant in human plasma. Anal Sci Adv. 2022;3(5-6):198-204.
[7] Yang DA, Laven RA. Performance of the StaphGold ELISA test in determining subclinical Staphylococcus aureus infections in dairy cows using a Gaussian mixture model. Vet Med Sci. 2022;8(4):1632-1639.
[8] Gaultier GN, Nix EB, Thorgrimson J, Boreham D, McCready W, Ulanova M. Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults. PLoS One. 2022;17(4).
How to cite this paper
ELISA Project—Detection, Optimizing, and Validation of Von Willebrand Factor
How to cite this paper: Yunting Xie. (2025) ELISA Project—Detection, Optimizing, and Validation of Von Willebrand Factor. International Journal of Clinical and Experimental Medicine Research, 9(1), 106-117.
DOI: http://dx.doi.org/10.26855/ijcemr.2025.01.018
More Articles
- Research Progress on Long-term Care Insurance
- Application Value and Advantages Analysis of Robot-assisted Radical Gastrectomy in the Treatment of Gastric Cancer Patients
- Impact of Vericiguat on Ventricular Remodeling and Cardiac Function in Patients with Chronic Severe Heart Failure
- Effect of Continuation Care on Compliance with Pelvic Floor Rehabilitation Training in Patients with Postpartum Stress Urinary Incontinence
- Clinical Analysis of 28 Cases of HELLP Syndrome
- Recent Advances in Diabetes Drug Therapy and Personalized Treatment Strategies